Announcements
- Bavarian Nordic konverterer eksisterende kreditfacilitet til bæredygtighedsrelateret lån
- Bavarian Nordic Converts Existing Credit Facility into Sustainability-linked Loan
- Bavarian Nordic Joins Global Efforts to Fight Mpox Outbreak in Africa
- Bavarian Nordic tilslutter sig globalt initiativ i kampen mod mpox i Afrika
- Bavarian Nordic indsender registreringsansøgning for chikungunyavaccine til de europæiske sundhedsmyndigheder
- Bavarian Nordic Submits Marketing Authorization Application for its Chikungunya Vaccine Candidate to EMA
- Bavarian Nordic Completes BLA Submission to U.S. FDA for its Chikungunya Vaccine Candidate
- Bavarian Nordic indsender registreringsansøgning for chikungunya-vaccine til de amerikanske sundhedsmyndigheder
- Bavarian Nordic indsender supplerende ansøgning til de amerikanske sundhedsmyndigheder om godkendelse af frysetørret koppe- og mpoxvaccine
- Bavarian Nordic Submits Supplemental BLA Seeking U.S. FDA Approval of Freeze-Dried Formulation of Smallpox and Mpox Vaccine
More ▼
Key statistics
On Monday, Bavarian Nordic A/S (BAVA:DEU) closed at 23.50, -9.13% below its 52-week high of 25.86, set on Jun 27, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 23.95 |
---|---|
High | 24.15 |
Low | 23.31 |
Bid | 23.33 |
Offer | 23.53 |
Previous close | 23.89 |
Average volume | 22.18k |
---|---|
Shares outstanding | 78.12m |
Free float | 78.05m |
P/E (TTM) | 13.71 |
Market cap | 13.77bn DKK |
EPS (TTM) | 12.86 DKK |
Data delayed at least 15 minutes, as of Jul 15 2024.
More ▼